Kaposi sarcoma · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-CHRONIC-HHV8-PREVENTION-IMMUNE-RESTORATION |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-KAPOSI |
| Sources | SRC-IARC-MONO-100B-2012 SRC-NIH-AIDS-2024 |
Notes
STUB — HHV-8 prevention anchor. v0.2-A continuation. ART regimen and mTOR-inhibitor conversion regimens not yet authored as REG-* entities.
Used By
Indication
IND-CHRONIC-HHV8-PREVENTION-OBSERVATION- IND-CHRONIC-HHV8-PREVENTION-OBSERVATIONIND-KAPOSI-1L-AIDS-ART- IND-KAPOSI-1L-AIDS-ARTIND-KAPOSI-1L-IATROGENIC-MTOR-CONVERSION- IND-KAPOSI-1L-IATROGENIC-MTOR-CONVERSION